Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.

Show other versions (1)
Bibliographic Details
Main Authors: Kitley, J, Leite, M, Elsone, L, Jacob, A, Palace, J
Format: Journal article
Language:English
Published: BMJ Publishing Group 2014

Similar Items